title: Activities of human alveolar macrophages (HAMs). Note 1: Observations on phagocytosis and bacterial killing in the presence of miocamycin.
abstract: We studied the activity of human alveolar macrophages (HAMs) obtained by bronchoalveolar lavage (BAL) from human lungs. In particular, we studied in vitro phagocytosis and bacterial killing in basal conditions and in the presence of miocamycin (MOM), a macrolide antibiotic. At a dose of 600 mg every 12 hours, MOM concentrations in the serum were 2.60 micrograms/ml 1 hour after administration and 0.75 microgram/ml 8 h after. The antibiotic cannot be assayed by the microbiological method in the acellular liquid of alveolar lavage. After penetrating the HAMs, it can be detected at a concentration of about 0.4 mcirograms/1.10(6) HAMs. MOM was able to penetrate HAM cytoplasm without altering their vitality. As a matter of fact, the Trypan blue exclusion dye test was not modified after long incubation in the presence of MOM. The HAMs, resuspended in a RPMI 1640 enriched medium, were able to phagocytize either live Staphylococci or inert Latex beads of 1 micron. MOM stimulated the HAM phagocytosis on both Staphylococci and Latex beads. The increase in Latex phagocytosis, a relatively inert substance on which MOM should not be active, is a confirmation of the antibiotic's directed stimulation of the HAMs. Finally, we have seen that the HAMs, which were noteworthy in killing the phagocytized bacteria, were stimulated by MOM after only 30 minutes of contact with the antibiotic.
authors.affiliation: Chair Phthisiology, University of Modena, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Capelli
authors.forename: O
authors.initials: O
authors.lastname: Capelli
authors.forename: L
authors.initials: L
authors.lastname: Azzolini
authors.forename: L
authors.initials: L
authors.lastname: Richeldi
authors.forename: E
authors.initials: E
authors.lastname: Prandi
authors.forename: G
authors.initials: G
authors.lastname: Velluti
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001992:Bronchoalveolar Lavage Fluid; D007933:Leucomycins / Q000494:pharmacology*; D008264:Macrophages / Q000187:drug effects*; D015644:Miocamycin; D010587:Phagocytosis / Q000187:drug effects*; D011650:Pulmonary Alveoli / Q000166:cytology / Q000276:immunology*
chemical_list: D000900:Anti-Bacterial Agents; D007933:Leucomycins; D015644:Miocamycin